4279 DisA nucleotide-binding domain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organic nitrogen compounds | 1 | 0.2 | 4.54× | not tested | |
| Nucleosides, nucleotides, and analogues | 6 | 1.9 | 3.15× | not tested | |
| Homogeneous non-metal compounds | 2 | 1.5 | 1.35× | not tested | |
| Lipids and lipid-like molecules | 1 | 0.8 | 1.30× | not tested | |
| Organoheterocyclic compounds | 1 | 1.1 | 0.94× | not tested | |
| Organic acids and derivatives | 1 | 1.1 | 0.94× | not tested | |
| Organic oxygen compounds | 1 | 1.4 | 0.73× | not tested | |
| Homogeneous metal compounds | 2 | 3.4 | 0.59× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00171 | ATP | ATP | 7 |
| DB00131 | AMP | Adenosine phosphate | 5 |
| DB01860 | 3AT | Cordycepin Triphosphate | 4 |
| DB02596 | APC | alpha,beta-Methyleneadenosine 5'-triphosphate | 4 |
| DB02175 | MLA | Malonic acid | 2 |
| DB00173 | ADE | Adenine | 1 |
| DB00640 | ADN | Adenosine | 1 |
| DB02210 | HEZ | Hexane-1,6-Diol | 1 |
| DB08357 | P4G | Diethylene glycol diethyl ether | 1 |
| DB16833 | ADP | Adenosine disphosphate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 31 |
| CL | CHLORIDE ION | 21 |
| 2BA | (2R,3R,3aS,5R,7aR,9R,10R,10aS,12R,14aR)-2,9-bis(6-amino-9H-purin-9-yl)octahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-3,5,10,12-tetrol 5,12-dioxide | 9 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 8 |
| AMP | ADENOSINE MONOPHOSPHATE | 5 |
| 3AT | 3'-DEOXYADENOSINE-5'-TRIPHOSPHATE | 4 |
| APC | DIPHOSPHOMETHYLPHOSPHONIC ACID ADENOSYL ESTER | 4 |
| MNmetal | MANGANESE (II) ION | 4 |
| NAmetal | SODIUM ION | 4 |
| TJ9 | ~{N}-[5-(2-azanyl-1,3-thiazol-4-yl)-4-methyl-1,3-thiazol-2-yl]ethanamide | 3 |
| 47U | N-(pyridin-2-yl)-2-(1,3,5-trimethyl-1H-pyrazol-4-yl)acetamide | 2 |
| AJO | 2-[cyanomethyl(methyl)amino]-N-(6-methylpyridin-2-yl)ethanamide | 2 |
| MLA | MALONIC ACID | 2 |
| RB7 | N-[(4-bromo-3-methylphenyl)methyl]-2-(methylsulfonyl)ethan-1-amine | 2 |
| SY4 | ~{N}-[5-azanyl-2,4-bis(fluoranyl)phenyl]propane-1-sulfonamide | 2 |
| SYV | 6-azanyl-3-methyl-1,3-benzoxazol-2-one | 2 |
| T9S | ethyl 1,3-dihydro-2H-pyrrolo[3,4-c]pyridine-2-carboxylate | 2 |
| TI5 | 5-methylpyrimidin-4-amine | 2 |
| UHL | 5-(2-methoxyethyl)-1,3,4-oxadiazol-2-amine | 2 |
| UI4 | 4-pyridin-2-ylphenol | 2 |